Premium Pemafibrate API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Pemafibrate (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Selective Peroxisome Proliferator-Activated Receptor Alpha Modulator (SPPARMα)

Indications: Hypertriglyceridemia (High Triglyceride Levels) / Dyslipidemia

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Pemafibrate distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Pemafibrate is a highly potent, orally active small-molecule Active Pharmaceutical Ingredient (API). In cardiovascular and metabolic pharmacology, it represents a significant structural and functional evolution from traditional fibrate drugs. It is classified specifically as a Selective Peroxisome Proliferator-Activated Receptor Alpha Modulator (SPPARMα).

Unlike legacy non-selective fibrates (such as fenofibrate or bezafibrate), Pemafibrate is engineered with a unique Y-shaped molecular structure that provides an exceptionally high binding affinity and selectivity for the PPARα nuclear receptor.

At the physiological level, the activation of PPARα by Pemafibrate regulates the transcription of genes involved in lipid metabolism. Specifically, it upregulates the expression of lipoprotein lipase (LPL) and downregulates apolipoprotein C-III (ApoC-III). This dual action significantly accelerates the clearance of triglyceride-rich lipoproteins from the bloodstream, efficiently lowering elevated serum triglycerides while simultaneously raising high-density lipoprotein cholesterol (HDL-C) levels.

Because of its high receptor selectivity, Pemafibrate achieves these lipid-lowering effects at a fraction of the dose required by older fibrates, significantly minimizing off-target renal and hepatic adverse events. For pharmaceutical formulation scientists, integrating this API allows for the development of modern, highly tolerable lipid-modulating therapeutics. In commercial manufacturing, this active ingredient is typically formulated into very low-dose (0.1 mg) immediate-release oral solid tablets.

Sourcing Pemafibrate in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced cardiovascular and metabolic formulations requires a highly resilient, traceable raw material pipeline. Procuring specialty SPPARMα APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Pemafibrate Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard batch or are scaling up a high-volume Pemafibrate api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during blending and tableting processes.

Technical Specifications for QA & R&D

The Pemafibrate API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards. A critical quality attribute for this compound is its enantiomeric purity, as Pemafibrate is a chiral molecule where the (R)-enantiomer is the active compound.

• Chemical Name: (2R)-2-[4-[2-(1,3-benzoxazol-2-yl(ethyl)amino)ethyl]phenoxy]-2-methylbutanoic acid
• CAS Number: 848259-27-8
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C28H30N2O6
• Molecular Weight: 490.55 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Chiral Purity: Strict control over the (S)-pemafibrate enantiomeric impurity (Impurity-1), ensuring maximum pharmacological efficacy.
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Pemafibrate is a highly potent metabolic modulator. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent chemical degradation.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, micronization, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.